ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,585.60
      -0.15%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      83.585
      0.03%
      Bitcoin
      61,403.09
      0.35%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Quoin Pharmaceuticals Ltd (QNRX)

      7. Quoin Pharmaceuticals Ltd (QNRX) News

      QNRX Quoin Pharmaceuticals Ltd

      0.76
      0.0069 (0.92%)
      May 08 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Quoin Pharmaceuticals Ltd QNRX NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0069 0.92% 0.76 19:59:59
      Open Price Low Price High Price Close Price Prev Close
      0.764 0.754 0.79 0.7899 0.7531
      more quote information »

      Recent News

      Date Time Source Heading
      5/08/20249:05IHNWFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      5/08/202416:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      5/02/202416:10GLOBEQuoin Pharmaceuticals to Announce First Quarter 2024..
      3/13/202416:05GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
      3/13/202407:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
      3/08/202416:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      3/08/202416:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      3/08/202416:01EDGAR2Form 8-K - Current report
      3/07/202416:05GLOBEQuoin Pharmaceuticals Announces Fourth Quarter and 2023..
      3/06/202417:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
      3/06/202416:01EDGAR2Form 8-K - Current report
      3/05/202408:00GLOBEQuoin Pharmaceuticals Announces Pricing of $6.5 Million..
      3/04/202417:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      3/04/202408:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Recruit..
      2/27/202406:01EDGAR2Form DEF 14A - Other definitive proxy statements
      2/15/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      2/13/202420:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/13/202416:50EDGAR2Form S-1/A - General form for registration of securities..
      2/13/202416:30EDGAR2Form PRE 14A - Other preliminary proxy statements
      2/12/202417:12EDGAR2Form S-1 - General form for registration of securities under..
      2/08/202408:00GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
      1/30/202416:05EDGAR2Form 8-K - Current report
      12/18/202317:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      12/18/202317:29EDGAR2Form 8-K - Current report
      12/13/202308:30GLOBEQuoin Pharmaceuticals Announces FDA Clearance of Clinical..
      11/09/202317:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      11/09/202317:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/09/202317:10EDGAR2Form 8-K - Current report
      11/08/202317:46GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
      11/07/202317:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      11/06/202316:17EDGAR2Form 8-K - Current report
      11/03/202308:41GLOBEQuoin Pharmaceuticals Announces Third Quarter 2023 Financial..
      11/01/202317:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      11/01/202316:59EDGAR2Form 8-K - Current report
      10/30/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/24/202309:32GLOBEREPEAT -- Quoin Pharmaceuticals Announces Additional..
      10/24/202308:28GLOBEQuoin Pharmaceuticals Announces Additional Positive Clinical..
      10/19/202317:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      9/14/202316:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      9/12/202306:03EDGAR2Form DEF 14A - Other definitive proxy statements
      9/01/202313:38EDGAR2Form PRE 14A - Other preliminary proxy statements
      8/03/202316:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      8/03/202314:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/02/202317:01EDGAR2Form 8-K - Current report
      8/02/202316:45GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
      7/27/202308:00GLOBEQuoin Pharmaceuticals Announces Second Quarter 2023..
      7/18/202316:43EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

      Your Recent History

      NASDAQ
      QNRX
      Quoin Pharmaceuticals
      Delayed Upgrade Clock